Navigation Links
McNeil Consumer Healthcare Announces a Voluntary Nationwide Recall of All Lots of TYLENOL(R) Arthritis Pain 100 Count With EZ-OPEN CAP
Date:12/18/2009

FORT WASHINGTON, Pa., Dec. 18, 2009 /PRNewswire/ -- In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is expanding its voluntary recall to include all available product lots of TYLENOL® Arthritis Pain Caplet 100 count bottles, with the distinctive red EZ-OPEN CAP (Full list of lot numbers provided below). In November 2009, 5 lots of this product were recalled due to consumer reports of an unusual moldy, musty, or mildew-like odor that was associated with nausea, stomach pain, vomiting and diarrhea. The recall is being expanded, as a precaution, to include all TYLENOL® Arthritis Pain Caplet 100 count bottles with the distinctive red EZ-OPEN CAP.

The uncharacteristic smell is caused by the presence of trace amounts of a chemical called 2,4,6-tribromoanisole. The source of 2,4,6-tribromoanisole is believed to be the breakdown of a chemical used to treat wooden pallets that transport and store packaging materials. The health effects of this compound have not been well studied, and to date all of the observed events reported to McNeil were temporary and non-serious.

Consumers who purchased TYLENOL® Arthritis Pain Caplet 100 count bottles with the distinctive red EZ-OPEN CAP from the lots included in this recall should stop using the product and contact McNeil for instructions on a refund or replacement. For these instructions or information regarding how to return or dispose of the product, consumers should call 1-888-222-6036 (Monday-Friday 8 a.m. to 8 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time) or log on to the internet at www.tylenol.com. Consumers who have medical concerns or questions should contact their healthcare provider. Any adverse reactions may also be reported to the FDA's MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.

The affected TYLENOL® Arthritis Pain Caplet 100 count product lot numbers can be found on the side of the bottle label. See the full list of affected product lot numbers below:

Recalled Product- Full List: http://www.tylenol.com/page2.jhtml?id=tylenol/news/subp_tar_recall.inc


                                                                 Product
    UPC #   NDC Code #                  Lot #                  Description
    -----   ----------               ---------                 -----------
    0045-    8382100  07CMC011, 07DMC022, 07DMC024, 07FMC032, TYLENOL(R)
     0838-21          07FMC033, 07GMC038, 07GMC039, 07HMC045, ARTHRITIS PAIN
                      07HMC051, 07HMC053, 07JMC064, 07JMC069, CAPLET 100 COUNT
                      07JMC070, 07JMC071, 07XMC055, 07XMC058, BOTTLES (with
                      07XMC062, 08AMC002, 08AMC005, 08CMC026, red EZ-OPEN CAP)
                      08DMC029, 08EMC037, 08EMC039, 08FMC044,
                      08FMC045, 08GMC050, 08GMC053, 08GMC063,
                      08GMC065, 08JMC103, 08JMC109, 08JMC110,
                      08JMC111, 08KMC124, 08KMC127, 08KMC131,
                      08KMC132, 08XMC093, 08XMC094, 08XMC095,
                      09AMC010, 09CMC041, 09EMC075, 09EMC079,
                      09EMC076, 09GMC096, 09GMC097, 09GMC099,
                      09JMC118, 09JMC126, 09KMC133, 09KMC134,
                      09XMC114, 09XMC116

Only the TYLENOL® Arthritis Pain Caplet 100's with the distinctive red EZ-OPEN CAP are affected by this action. All other TYLENOL® Arthritis Pain products remain commercially available. McNeil Consumer Healthcare will reintroduce the TYLENOL® Arthritis Pain Caplet 100 count product by January, 2010 after moving production to a new facility.

McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. markets a broad range of well-known and trusted over-the-counter (OTC) products around the globe. McNeil Consumer Healthcare is most widely recognized for the complete line of TYLENOL® acetaminophen products, the leading pain reliever brand in the adult and pediatric categories.

SOURCE McNeil Consumer Healthcare


'/>"/>
SOURCE McNeil Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
2. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
3. McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP
4. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
5. Consumer Advocates Support Patent Office on Stem Cell Patent Rejection
6. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
7. Dog Law Officers Crackdown on Unsatisfactory Kennels Protecting Animals, Consumers
8. Survey Finds At-Risk Consumers Interested in OTC Statin
9. Florastor(R) Receives ConsumerLab.com Certification
10. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
11. Consumer Group Urges Gov. Schwarzenegger to Sign Stem Cell Bill Into Law
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Injectables Market and Increasing Usage of Complex Biologics during the Forecast ... ... USD 20 Billion in 2015 to around USD 26 Billion by ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for Health Care ... of America (HCAOA). This agreement allows HCAOA members to receive special pricing on ... on Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Bill Howe ... industry in the coastal communities. After Tina Howe joined the team, the Bill Howe ... employees, honest services at affordable rates, and giving back to the San Diego community ...
Breaking Medicine News(10 mins):